Effects of quetiapine on cognitive functions in schizophrenic patients: A preliminary single-trial ERP analysis

Pharmacopsychiatry

Volumn 42, Issue 4, 2009, Pages 129-134

  Zhang, Y ^a   Lehmann, M ^b   Shobeiry, A ^a   Hofer D ^a   Johannes, S ^c   Emrich, H M ^a   Dietrich, D E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Architecture of Drägerwerk AG and Co KGaA   (Germany)

^c Clinic for Neurorehabilitation Bellikon   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; EYELID REFLEX; HUMAN; MEMORY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM CHECKLIST 90; TASK PERFORMANCE; WORD RECOGNITION; BRAIN; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PERCEPTIVE DISCRIMINATION; RECOGNITION;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; COGNITION; COGNITION DISORDERS; DIBENZOTHIAZEPINES; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA; SIGNAL DETECTION, PSYCHOLOGICAL; YOUNG ADULT;

EID: 70249108188     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1112133     Document Type: Article

References (24)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, (DSM-IV). Washington, DC: American Psychiatric Association ; 1994
2. Basar E. Wavelet analysis of brain waves In: Brain Function and Oscillations, Part I: Brain Oscillations: Principles and Approaches. Berlin: Springer-Verlag ; 1998 ; 107-121
3. Bramon E, Rabe-Hesketh S, Sham P et al. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 2004 ; 70 : 315-329
4. Dietrich DE, Emrich HM, Waller C et al. Emotion/cognition-coupling in word recognition memory of depressive patients: an event-related potential study. Psychiatry Res 2000 ; 96 : 15-29
5. Dietrich DE, Hauser U, Peters M et al. S100B blood levels and target evaluation processes in remitted patients with recurrent major depression. Neurosci Lett 2004 ; 354 : 69-73
6. Dietrich DE, Kleinschmidt A, Hauser U et al. Word recognition memory before and after successful treatment of depression. Pharmacopsychiatry 2000 ; 33 : 221-228
7. G ö der R, Fritzer G, Gottwald B et al. Effects of olanzapine on slow wave sleep, sleep spindles and sleep-related memory consolidation in schizophrenia. Pharmacopsychiatry 2008 ; 41 : 92-99
8. Hillyard SA, Mangun GR, WoldorffMG et al. Neural System Mediating Selective Attention In: Gazzaniga MS, ed. The Cognitive Neurosciences. Cambridge: MIT Press ; 1995 ; 665-682
9. Hillyard SA, Picton TW. Electrophysiology of cognition In: Plum F, ed. Handbook of Physiology, Section 1: Neurophysiology. New York: American Physiological Society ; 1987 ; 519-584
10. Iwanami A, Okajima Y, Isono H et al. Effects of risperidone on eventrelated potentials in schizophrenic patients. Pharmacopsychiatry 2001 ; 34 : 73-79
11. Jann MW. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis . Pharmacotherapy 2004 ; 24 : 1759-1783
12. Johannes S, Wieringa BM, Manthey M et al. Altered inhibition of motor responses in Tourette syndrome and obsessive-compulsive disorder. Acta Neurol Scand 2001 ; 104 : 36-43
13. Johnson R. Event-related potential insights into the neurobiology of memory systems In: Boller F, Grafman J, eds., Handbook of neuropsychology . Amsterdam: Elsevier ; 1995 ; 10 : 135-163
14. Jones HM, Brammer MJ, O ' Toole M et al. Cortical effects of quetiapine in fi rst-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biol Psychiatry 2004 ; 56 : 938-942
15. Luck SJ. An Introduction to the Event-Related Potential Technique. London: MIT Press ; 2005
16. Meltzer HY, MacGurk SR. The effects of clozapine, risperidone, and quetiapine on cognitive function in schizophrenia. Schizophrenia Bull 1999 ; 25 : 233-255
17. Molina V, Mu ñ oz F, Mart í n-Loeches M et al. Long-term olanzapine treatment and p300 parameters in schizophrenia. Neuropsychobiology 2004 ; 50 : 182-188
18. Molina V, Reig S, Sanz J et al. Changes in cortical volume with olanzapine in chronic schizophrenia. Pharmacopsychiatry. 2007 ; 40 : 135-139
19. Purdon SE, Jones BD, Stip E et al. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Group for research in schizophrenia . Arch Gen Psychiatry 2000 ; 57 : 249-258
20. Purdon SE, Malla A, Labelle A et al. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 2001 ; 26 : 137-149
21. Rugg MD. Event-Related Potential Studies of Human Memory. In: Gazzaniga MS, ed. The Cognitive Neurosciences. Cambridge: Bradford Book ; 1995 ; 789-801
22. Velligan DI, Prihoda TJ, Sui D et al. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 2003 ; 64 : 524-531
23. Woodward ND, Purdon SE, Meltzer HY et al. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 2005 ; 8 : 457-472
24. Zhang Y, Ennen J, Lehmann M et al. Memory and attention processes in schizophrenic patients treated with olanzapine: a single-trial ERP analysis. Der Nervenarzt 2006 ; (Suppl. 3) : 156